在干细胞治疗中取得的进展,用于治疗耐药性
1Department of Pathology, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia. mhhamed@uqu.edu.sa.
干细胞疗法显示,通过促进神经修复和减少发作,对抗药性有前途. 这种方法提供了潜在的再生效益,超出了这种慢性神经疾病的传统治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 影响全球数百万人,尽管目前的治疗方法,但20-30%的人患有耐药性形式.
- 耐药性通常涉及神经元损伤,氧化应激和线粒体功能障碍.
- 现有的治疗方法可能无法完全解决持续性的潜在病理问题.
研究的目的:
- 审查最近干细胞治疗的进展.
- 探索干细胞在模型中提出的机制和干细胞的治疗作用.
- 考虑辅助再生医学方法,以获得更好的结果.
主要方法:
- 动物研究和早期临床研究对的干细胞移植的综述.
- 对干细胞种群的分析,包括ESC,MSC,NSC,iPSC和ADRC.
- 检查建议的机制,如神经保护和网络恢复.
主要成果:
- 干细胞移植可以恢复抑制性神经元网络并减少神经炎症.
- 有证据表明,干细胞可以促进受伤神经回路的修复,帮助控制发作.
- 在临床前模型中,各种干细胞类型显示出再生和神经保护的潜力.
结论:
- 干细胞疗法为耐药性提供了一个有前途的治疗途径.
- 针对潜在生物学的再生方法可能提供更持久的控制.
- 将干细胞治疗与神经保护和电刺激相结合,可以改善结果.
更多相关视频
05:00Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
Published on: November 11, 2022
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
iPS Cell Differentiation
Antiepileptic Drugs: Glutamate Antagonists
EPS and iPS Cells in Disease Research
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
